Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr. Shamir Mehta, McMaster University
ClinicalTrials.gov Identifier:
NCT00317252
First received: April 20, 2006
Last updated: October 19, 2012
Last verified: October 2012